BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18926282)

  • 1. DNA methylation: its role in cancer development and therapy.
    Kurkjian C; Kummar S; Murgo AJ
    Curr Probl Cancer; 2008; 32(5):187-235. PubMed ID: 18926282
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action.
    Lübbert M
    Curr Top Microbiol Immunol; 2000; 249():135-64. PubMed ID: 10802943
    [No Abstract]   [Full Text] [Related]  

  • 3. Decitabine and its role in the treatment of hematopoietic malignancies.
    Plimack ER; Kantarjian HM; Issa JP
    Leuk Lymphoma; 2007 Aug; 48(8):1472-81. PubMed ID: 17701577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA methylation.
    Issa JP; Kantarjian HM
    Clin Cancer Res; 2009 Jun; 15(12):3938-46. PubMed ID: 19509174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
    Stewart DJ; Issa JP; Kurzrock R; Nunez MI; Jelinek J; Hong D; Oki Y; Guo Z; Gupta S; Wistuba II
    Clin Cancer Res; 2009 Jun; 15(11):3881-8. PubMed ID: 19470736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
    Samlowski WE; Leachman SA; Wade M; Cassidy P; Porter-Gill P; Busby L; Wheeler R; Boucher K; Fitzpatrick F; Jones DA; Karpf AR
    J Clin Oncol; 2005 Jun; 23(17):3897-905. PubMed ID: 15753459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplasia, megakaryocytes, and methylation.
    Steensma DP
    Leuk Res; 2004 Aug; 28(8):775-6. PubMed ID: 15203274
    [No Abstract]   [Full Text] [Related]  

  • 9. [Demethylating medication in myelodysplastic syndrome].
    Manson ML; Derissen EJ; Wijermans PW; Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2012; 156(4):A3167. PubMed ID: 22278034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decitabine.
    Daskalakis M; Blagitko-Dorfs N; Hackanson B
    Recent Results Cancer Res; 2010; 184():131-57. PubMed ID: 20072836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine is an effective treatment of idiopathic myelofibrosis.
    Danilov AV; Relias V; Feeney DM; Miller KB
    Br J Haematol; 2009 Apr; 145(1):131-2. PubMed ID: 19133981
    [No Abstract]   [Full Text] [Related]  

  • 12. Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy.
    Steensma DP; Friday BB
    Leuk Lymphoma; 2007 Aug; 48(8):1628-9. PubMed ID: 17701595
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer prevention: epigenetics steps up to the plate.
    Issa JP
    Cancer Prev Res (Phila); 2008 Sep; 1(4):219-22. PubMed ID: 19138962
    [No Abstract]   [Full Text] [Related]  

  • 15. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
    Aparicio A; North B; Barske L; Wang X; Bollati V; Weisenberger D; Yoo C; Tannir N; Horne E; Groshen S; Jones P; Yang A; Issa JP
    Epigenetics; 2009 Apr; 4(3):176-84. PubMed ID: 19421002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
    Lowder JN; Taverna P; Issa JP
    Epigenomics; 2015 Oct; 7(7):1083-8. PubMed ID: 26541345
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy for myelodysplastic syndrome: building evidence for action.
    Tefferi A; Letendre L
    Cancer; 2006 Apr; 106(8):1650-2. PubMed ID: 16532501
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer.
    Momparler RL; Ayoub J
    Lung Cancer; 2001 Dec; 34 Suppl 4():S111-5. PubMed ID: 11742714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of epigenetics in cancer. DNA Methylation, Imprinting and the Epigenetics of Cancer--an American Association for Cancer Research Special Conference. Las Croabas, Puerto Rico, 12-16 1997 December.
    Lengauer C; Issa JP
    Mol Med Today; 1998 Mar; 4(3):102-3. PubMed ID: 9575489
    [No Abstract]   [Full Text] [Related]  

  • 20. Decitabine. MGI Pharma Inc/SuperGen Inc.
    Arthur C
    IDrugs; 2004 Dec; 7(12):1113-32. PubMed ID: 15599805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.